Health Care & Life Sciences » Biotechnology | Shanghai Hile Bio-Technology Co. Ltd.

Shanghai Hile Bio-Technology Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
-
693
755
672
466
Total Accounts Receivable
-
31
31
42
75
Inventories
-
34
40
100
129
Other Current Assets
-
29
2
5
117
Total Current Assets
-
788
829
818
787
Net Property, Plant & Equipment
-
373
463
501
542
Total Investments and Advances
-
-
10
115
25
Intangible Assets
-
66
129
115
337
Other Assets
-
-
25
19
28
Total Assets
-
1,240
1,480
1,602
1,749
ST Debt & Current Portion LT Debt
-
81
302
Accounts Payable
34
103
68
Income Tax Payable
11
9
10
Other Current Liabilities
60
66
78
Total Current Liabilities
106
259
457
Long-Term Debt
86
130
-
Deferred Taxes
13
25
34
Total Liabilities
192
389
457
Common Equity (Total)
924
982
1,070
Total Shareholders' Equity
924
982
1,070
Total Equity
963
1,005
1,075
Liabilities & Shareholders' Equity
1,240
1,480
1,602
Accumulated Minority Interest
39
24
5
Non-Equity Reserves
85
85
69

About Shanghai Hile Bio-Technology Co.

View Profile
Address
No. 6720 Jinhai Road
Shanghai Shanghai 201403
China
Employees -
Website http://www.hile-bio.com
Updated 07/08/2019
Shanghai Hile Bio-Technology Co., Ltd. engages in the manufacture and sale of veterinary vaccine and inactivated vaccine. It specializes in pig, poultry, and pet vaccine products. It offers inactivated rabies vaccines, avian infectious bronchitis vaccine, swine fever vaccine, porcine transmissible gastroenteritis and porcine epidemic diarrhea bivalent inactivated vaccine, highly pathogenic blue ear pig disease vaccine, porcine reproductive and respiratory syndrome vaccine, and porcine circovirus type 2 inactivated vaccine.